Alexza Pharma (ALXA) Posts Q4 GAAP EPS of $0.42
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ALXA Hot Sheet
Price: $0.92 --0%
Financial Fact:
Interest and other income/ (expense), net: 115K
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Interest and other income/ (expense), net: 115K
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Alexza Pharmaceuticals Inc. (NASDAQ: ALXA) reported Q4 GAAP EPS of $0.42, which may not compare to the analyst estimate of $0.09. Revenue for the quarter came in at $42.1 million versus the consensus estimate of $20.88 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Marriott Vacations Worldwide (VAC) Tops Q3 EPS by 7c; offers guidance
- Studio City International Holdings Limited (MSC) Reports Q3 Loss of $0.02
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
